LysoPE(18:0/0:0)
|
Basic information |
| Metabolite name | LysoPE(18:0/0:0) |
 | HMDB0011130 |
 |
C21484 |
 |
9547068 |
| Synonyms | NA |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | LysoPE(18:0/0:0) |
| HMDB0011130 |
|
C21484 |
|
9547068 |
| Synonyms | NA |
| No. of studies | 8 |
|
Relationship between LysoPE(18:0/0:0) and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1047 | Type2 | CSDS + 3,4-methylenedioxymethamphetamine group vs. CSDS group | Plasma | C57BL/6 mouse | Up |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M604 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M608 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M608 | Type2 | CUMS + Poria cocos group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M632 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Unknown |
| Study M689 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M689 | Type2 | CUMS + Danzhi Xiaoyao Powder group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M769 | Type1 | CSDS group vs. control group | Amygdala | Sprague-Dawley rat | Up |
| Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |
| Study M869 | Type2 | CUMS + high dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |